Group 1 - The core point of the article is that Tiankang Biological announced the acquisition of a 51% stake in Xinjiang Qiangdu Animal Husbandry Technology Co., Ltd. during a board meeting held on December 11, 2025 [1] - The revenue composition of Tiankang Biological for the first half of 2025 is as follows: pig farming accounts for 32.2%, feed accounts for 27.51%, agricultural product processing accounts for 16.37%, corn storage accounts for 14.75%, and veterinary medicine accounts for 5.44% [1] - As of the report date, Tiankang Biological has a market capitalization of 9.5 billion yuan [1]

Core Viewpoint - TianKang Biological announced the resignation of its general manager, Cheng Hui, due to approaching retirement age, while appointing Xu Heng as the new general manager [1] Company Summary - Cheng Hui's resignation was accepted by the board, and he will continue to serve as a director and a member of the Strategic and Investment Committee [1] - The company's revenue composition for the first half of 2025 is as follows: pig farming 32.2%, feed 27.51%, agricultural product processing 16.37%, corn storage 14.75%, and veterinary medicine 5.44% [1] - As of the report, TianKang Biological has a market capitalization of 9.8 billion yuan [1]

Group 1 - The company TianKang Biological (SZ 002100) held its 28th temporary board meeting on October 29, 2025, via communication voting to review the "2025 Q3 Report" and other documents [1] - For the first half of 2025, the revenue composition of TianKang Biological was as follows: pig farming accounted for 32.2%, feed accounted for 27.51%, agricultural product processing accounted for 16.37%, corn storage industry accounted for 14.75%, and veterinary medicine accounted for 5.44% [1] - As of the report date, the market capitalization of TianKang Biological was 10.6 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market transformation and a new "slow bull" pattern emerging [1]

Company Overview - TianKang Biological announced the resignation of Deputy General Manager Zheng Dongsheng due to personal work adjustments, effective immediately upon submission to the board [1] - After his resignation, Zheng Dongsheng will no longer hold any positions within the company or its subsidiaries [1] Financial Performance - For the first half of 2025, TianKang Biological's revenue composition is as follows: pig farming accounted for 32.2%, feed accounted for 27.51%, agricultural product processing accounted for 16.37%, corn storage accounted for 14.75%, and veterinary medicine accounted for 5.44% [1] - As of the report date, TianKang Biological has a market capitalization of 9.2 billion yuan [1]